FDA-cleared profile

uMR Omega with uWS-MR-MRS

Shanghai United Imaging Healthcare Co.,Ltd. · MRI · FDA-cleared (510(k))

Authorized purpose: MR diagnostic system producing cross-sectional and spectroscopic images of internal anatomy and function; uWS-MR provides viewing, manipulation, communication, storage, and application-specific post-processing.

Clinical role
MR diagnostic system producing cross-sectional and spectroscopic images of the head, body and extremities for interpretation by a trained physician, with uWS-MR software for viewing, manipulation, communication, and storage of medical images.
Images and patients
MRI · Head, body, and extremities
Key limitation
Keep in mind: Interpretation is by a trained physician; feature, body-part, and protocol scope is application-specific; additional exact FDA limitations are unknown.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: MR diagnostic system producing cross-sectional and spectroscopic images of internal anatomy and function; uWS-MR provides viewing, manipulation, communication, storage, and application-specific post-processing.
  • Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Head, body, and extremities Input: MR images, MR spectroscopy data, and sequence-specific datasets; contrast may be used depending on the scan region.
  • Who uses it?Intended users: Trained physicians; other operator roles are not specified.
  • What does the software produce?Output: Cross-sectional and spectroscopic images, parameter maps, flow and cardiac data, spectroscopy outputs, AI-assisted compressed-sensing reconstructions, and DeepRecon denoised/super-resolution images.
  • What is its most important limitation?Key limitation: Interpretation is by a trained physician; feature, body-part, and protocol scope is application-specific; additional exact FDA limitations are unknown.

Clinical takeaway. Clinical role: MR diagnostic system producing cross-sectional and spectroscopic images of internal anatomy and function; uWS-MR provides viewing, manipulation, communication, storage, and application-specific post-processing.

Evidence takeaway. Evidence from the reviewed source record: FDA packet reports standards-based hardware/software verification and DeepRecon testing in 77 independent US subjects; the 77-subject result applies to DeepRecon image-quality testing, not the entire system, and other feature sample sizes are not stated.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
MR diagnostic system producing cross-sectional and spectroscopic images of internal anatomy and function; uWS-MR provides viewing, manipulation, communication, storage, and application-specific post-processing.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled in this remediation finding.

Workflow role
MR diagnostic system producing cross-sectional and spectroscopic images of the head, body and extremities for interpretation by a trained physician, with uWS-MR software for viewing, manipulation, communication, and storage of medical images.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The uMR Omega system is indicated for use as a magnetic resonance diagnostic device (MRDD) that produces sagittal, transverse, coronal, and oblique cross sectional images, and spectroscopic images, and that display internal anatomical structure and/or function of the head, body and extremities." … "These images and the physical parameters derived from the images when interpreted by a trained physician yield information that may assist the diagnosis.". Read from the exact FDA decision document on 2026-11-14.

Required input
MR images, MR spectroscopy data, and sequence-specific datasets; contrast may be used depending on the scan region.
  • Exact FDA submission
  • Checked 2026-09-19

FDA device description and intended use.

Output and clinician action
Cross-sectional and spectroscopic images, parameter maps, flow and cardiac data, spectroscopy outputs, AI-assisted compressed-sensing reconstructions, and DeepRecon denoised/super-resolution images.
  • Exact FDA submission
  • Checked 2026-09-19

FDA device description and feature tables.

Care setting
Healthcare institutions, where the uWS-MR software supports interpretation and evaluation of examinations; the FDA document does not specify a patient population.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "uWS-MR is a software solution intended to be used for viewing, manipulation, communication, and storage of medical images. It supports interpretation and evaluation of examinations within healthcare institutions.". Read from the exact FDA decision document on 2026-11-14.

Intended users
Trained physicians; other operator roles are not specified.
  • Exact FDA submission
  • Checked 2026-09-19

FDA intended-use interpretation boundary.

Limitations
Interpretation is by a trained physician; feature, body-part, and protocol scope is application-specific; additional exact FDA limitations are unknown.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA boundary without adding deployment or compatibility claims.

Evidence summary
FDA packet reports standards-based hardware/software verification and DeepRecon testing in 77 independent US subjects; the 77-subject result applies to DeepRecon image-quality testing, not the entire system, and other feature sample sizes are not stated.
  • Exact FDA submission
  • Checked 2026-09-19

Submission-reported feature-specific testing; not a unified 77-case system study.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA packet reports standards-based hardware/software verification and DeepRecon testing in 77 independent US subjects; the 77-subject result applies to DeepRecon image-quality testing, not the entire system, and other feature sample sizes are not stated.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Submission-reported feature-specific testing; not a unified 77-case system study.

Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

uMR Omega with uWS-MR-MRS regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationPopulation described in the exact-submission ACR model card
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K220332
  • Samplen=77
  • IndependenceIndependence not established

K220332

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K220332. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: MR images, MR spectroscopy data, and sequence-specific datasets; contrast may be used depending on the scan region.

    Scope: Exact FDA submission. FDA device description and intended use.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K220332: uMR Omega with uWS-MR-MRS

  2. Routing

    Unresolved route: Not established for the exact route.

    Scope: Exact FDA submission. The exact FDA decision document was reviewed on 2026-11-14 and does not state the subject device's DICOM, PACS, RIS, or EHR interfaces. Confirm supported DICOM services and PACS, RIS, EHR, and interface versions with the vendor.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-11-14 ·

  3. AI processing

    Unresolved route: Not established for the exact route.

    Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-09 ·

  4. Returned objects

    Source context, not route validation: Cross-sectional and spectroscopic images, parameter maps, flow and cardiac data, spectroscopy outputs, AI-assisted compressed-sensing reconstructions, and DeepRecon denoised/super-resolution images.

    Scope: Exact FDA submission. FDA device description and feature tables.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K220332: uMR Omega with uWS-MR-MRS

  5. Viewer/worklist/report

    Unresolved route: Cross-sectional and spectroscopic images, parameter maps, flow and cardiac data, spectroscopy outputs, AI-assisted compressed-sensing reconstructions, and DeepRecon denoised/super-resolution images.

    Scope: Exact FDA submission. FDA device description and feature tables.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K220332: uMR Omega with uWS-MR-MRS

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Security
United Imaging Healthcare's cybersecurity page lists a secure development lifecycle and controls: firewall, encrypted connections, OS hardening, antivirus, patches, authentication, audit log, disk and transmission encryption. Company-level, not release-specific.
  • Vendor-wide
  • Checked 2026-10-25

Vendor statement, not an attestation; exact-release scope is not established.

Supported acquisition environment

Scanner manufacturers: All

exact submission · checked 2026-09-01

Confirm currently supported software versions, protocols, and site-specific acquisition configurations.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for uMR Omega with uWS-MR-MRS; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K220332
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
MRI
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

FDA magnetic-resonance scope.

Anatomy
Head, body, and extremities
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

FDA intended use; feature-specific examples include brain, breast, liver, prostate, vascular, and cardiac applications.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2022-10-27
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
24Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K220332 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Deployment: Not verified - checked 2026-09-09 - Exact FDA submission

    The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.

  • Integration: Not publicly available - checked 2026-11-14 - Exact FDA submission

    The exact FDA decision document was reviewed on 2026-11-14 and does not state the subject device's DICOM, PACS, RIS, or EHR interfaces. Confirm supported DICOM services and PACS, RIS, EHR, and interface versions with the vendor.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-09 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K220332: uMR Omega with uWS-MR-MRS

    U.S. Food and Drug Administration - Published 2022-10-27 - Accessed 2026-09-09

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, purpose, intendedUsers, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. uMR Omega with uWS-MR-MRS model card (K220332)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, output, limitations, evidenceSummary, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K220332

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

  8. United Imaging Healthcare Cybersecurity

    United Imaging Healthcare - Accessed 2026-10-25

    Scope: security

Research history

  1. K220332 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260113

uMR Astra

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMR Astra is a diagnostic MR system for cross-sectional and spectroscopic imaging of the labeled head, body, and extremities.

Modality
MRI
Anatomy
Head; body; and extremities
Decision
2026-05-22
FDA-cleared K253648

Ingenia, Ingenia CX, Ingenia Elition S/X, Ingenia Ambition S/X, BlueSeal SE/XE/QE, MR 5300 and MR 7700 MR Systems including Upgrades

Philips Medical Systems Nederland B.V.

Authorized purpose: The Ingenia, Ingenia CX, Elition, Ambition, BlueSeal, MR5300, and MR7700 systems produce diagnostic MR images, spectra, and physical parameters of the head, body, and extremities for trained physician interpretation.

Modality
MRI
Anatomy
Head, body, and extremities
Decision
2026-02-23
FDA-cleared K260265

MAGNETOM Flow.Ace; MAGNETOM Flow.Plus

Siemens Shenzhen Magnetic Resonance, Ltd.

Authorized purpose: MAGNETOM Flow.Ace and Flow.Plus are diagnostic MR systems that produce transverse, sagittal, coronal, and oblique images, spectroscopic images and spectra, and labeled information about internal structure and function.

Modality
MRI
Anatomy
Head, body, and extremities
Decision
2026-02-23
FDA-cleared K252371

uMR 680

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMR 680 is a 1.5T MRI system that produces transverse, sagittal, coronal, oblique, and spectroscopic images and physical parameters of the head, body, and extremities, including the labeled mobile configuration.

Modality
MRI
Anatomy
Head, body, and extremities
Decision
2025-09-25

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history